Senate Appropriations Committee
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee
A Review of the President’s Fiscal Year 2025 Budget Request for the Food and Drug Administration
Subcommittee hearing of the $7.2 billion Food and Drug Administration budget request.
Chair Martin Heinrich (D-N.M.)
Witness:- Dr. Robert M. Califf, Commissioner, Food and Drug Administration
The FY 2025 President’s Budget provides $8.0 million for Modernization of Cosmetics Implementation, for the Office of the Chief Scientist (OCS). These resources will be used to hire additional staff for continued strategic coordination and implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Resources will be used for activities to develop proposed and/or final regulations (for Good Manufacturing Practices, asbestos testing of talc-containing cosmetics products, and disclosing fragrance allergens on labeling) and compliance policies. Funds will also be used to maintain and update submission platforms to address MoCRA provisions for registration, product listing, and adverse event reporting, as well as review of such information to ensure industry compliance with those requirements. The new funding would also support hiring additional experts to manage critical projects such as assessments of the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products. FDA will hire staff across OCS and the Office of Cosmetics and Colors to enable FDA to work toward a modernized cosmetics regulatory program.